Seattle, WA, United States of America

Jonathan David Clapper

USPTO Granted Patents = 2 



Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 57(Granted Patents)


Location History:

  • University Place, WA (US) (2011)
  • Seattle, WA (US) (2014)

Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jonathan David Clapper

Introduction

Jonathan David Clapper is a notable inventor based in Seattle, WA, who has made significant contributions to the field of hematological malignancies. With a total of 2 patents to his name, Clapper's work focuses on the detection, diagnosis, and therapy of various blood cancers, including B cell leukemias and lymphomas.

Latest Patents

Clapper's latest patents include innovative methods and compositions aimed at improving the detection and treatment of hematological malignancies. These patents disclose methods for eliciting immune and T cell responses to specific malignancy-related antigenic polypeptides. Additionally, they provide compositions and methods for identifying cells and biological samples that contain hematological malignancy-related compositions. The patents also encompass diagnostic and therapeutic kits designed for the diagnosis, therapy, and prevention of a variety of leukemias and lymphomas.

Career Highlights

Jonathan David Clapper is associated with Corixa Corporation, where he has been instrumental in advancing research related to hematological malignancies. His work has contributed to the development of new diagnostic and therapeutic approaches that have the potential to improve patient outcomes.

Collaborations

Clapper has collaborated with notable colleagues, including Alexander Gaiger and Paul Algate, to further enhance the research and development of innovative solutions in the field of hematology.

Conclusion

Jonathan David Clapper's contributions to the field of hematological malignancies through his patents and work at Corixa Corporation highlight his commitment to advancing medical science. His innovative approaches have the potential to significantly impact the diagnosis and treatment of blood cancers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…